H. Slooten

发表

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

S. Jansen, A. Stiggelbout, M. Nooij, 2001, British Journal of Cancer.

Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells

J. H. Dierendonck, S. Erkeland, R. Keijzer, 2000, Cell Death and Differentiation.

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity

M. Vijver, J. H. Dierendonck, H. Slooten, 1998, British Journal of Cancer.

How important is the opinion of significant others to cancer patients’ adjuvant chemotherapy decision-making?

W. Otten, S. Jansen, A. Stiggelbout, 2007, Supportive Care in Cancer.

O,p′-DDD (Mitotane) levels in plasma and tissues during chemotherapy and at autopsy

H. Slooten, A. Seters, A. Moolenaar, 2004, Cancer Chemotherapy and Pharmacology.

Blood levels of o,p′-DDD following administration in various vehicles after a single dose and during long-term treatment

H. Slooten, A. Seters, A. Moolenaar, 2004, Cancer Chemotherapy and Pharmacology.

THE INFLUENCE OF BROMOCRIPTINE ON SERUM LEVELS OF GROWTH HORMONE AND OTHER PITUITARY HORMONES AND ITS METABOLIC EFFECTS IN ACTIVE ACROMEGALY

F. Roelfsema, H. Slooten, B. Goslings, 1979, Clinical endocrinology.

Morphologic characteristics of benign and malignant adrenocortical tumors

H. Slooten, Henk V. Slooten, Aard Schaberg, 1985, Cancer.

Comparison of the effects of microwave heating and high pressure cooking for antigen retrieval of human and rat Bcl-2 protein in formaldehyde-fixed, paraffin-embedded sections

J. H. Dierendonck, R. Keijzer, R. W. Hoetelmans, 2002, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

Local recurrence (LR) after breast-conserving therapy (BCT) in node-negative premenopausal patients: Influence of perloperative chemotherapy (PeCT)

M. Vijver, P. Elkhuizen, P. Clahsen, 1998 .

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

M. J. van de Vijver, A. Mandard, C. J. van de Velde, 1996, British Journal of Cancer.

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.

C. Cornelisse, H. Smith, B. Bonsing, 1995, British Journal of Cancer.

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.

J. Hermans, D. Bruinvels, R. Tollenaar, 1998, British Journal of Cancer.

Abstract PD02-03: Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification (MLPA)

S. Al-Janabi, P. Diest, J. Hinrichs, 2012 .

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.

M. J. van de Vijver, C. J. van de Velde, J. V. van Dierendonck, 1998, British Journal of Cancer.